Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot evaluation of switching from efavirenz to maraviroc in virologically suppressed HIV-1 patients
2009-014694-40Phase 4Completed
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV). Primary endpoint: Steady-state plasma concentrations of maraviroc. Started Oct 2009; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2009-014694-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014694-40.